Cell therapy

Microbiome may influence the health of some people diagnosed with autism

A collaborative study involving Israel, the US, Europe, Ecuador, Russia, and China reveals promising insights into the gut-brain axis in autism spectrum disorder.

 The brain (illustrative).
 Immunai CEO Noam Solomon

Immunai, BCM developing first-in-human cell therapy for neuroblastoma

 What are the scientific processes behind aging?

New research uncovers method to prevent DNA breakdown, aging - study

 The brain

'Sneaky' cancer tumors create shelters to hide from immunotherapy - study


First time in Israel: Adult stem cells transplanted in toddler with rare skin disease

The first transplantation of the mesenchymal stem cells (MSC) was given as part of compassionate treatment to a two-and-a-half-year-old boy suffering from epidermolysis bullosa (EB).

 First time in Israel: Multipotent adult stem cells transplanted – in a toddler with rare genetic skin disease.

AI system developed to determine optimal conditions for regenerative medicine

A robotic AI system has been developed by scientists that is capable of improving stem cell culture procedures that are utilized in regenerative medicine. 

A magnified view of a CD34+ stem cell

Cell therapy co. Gamida Cell announces USD 75 m. financing

Gamida Cell is a cell therapy company working to develop and commercialize cures for blood cancers and blood diseases.

CEO of Gamida Cell Dr. Julian Adams

Pluristem to terminate Phase III study of critical limb ischemia (CLI)

While the CLI study was unsuccessful, Yanay said the company is maintaining a forward-thinking attitude, looking toward the development of other treatments it has in the works.

Biologists work in a laboratory at Pluristem Theraputics in Haifa

Investigational drug proven to prolong survival of ALS patients - study

The median overall survival for all CENTAUR study participants being administered AMX0035 was 6.5 months longer than the group originally randomized to placebo.

Prof. Boaz Lerner of Ben-Gurion University uses a new platform for predicting ALS disease progression

Israel’s Immunai first to map whole immune system, scores $20m. investment

Immunai says it has mapped out millions of immune cells and their functions that could help detect, diagnose and treat cancer and many other diseases.

Immunai co-founders (from left) Luis Voloch and Noam Solomon

Israeli cell therapy company offers solution after failed Russian experiment

Radiation poisoning, known in the medical world as acute radiation syndrome or ARS, is a grave illness that often leads to death.

Biologists work in a laboratory at Pluristem Theraputics in Haifa

Pluristem gets positive results from radiation treatment trials

“We believe that this outcome is an important contribution to protect the armed and medical forces which may need to enter contaminated areas,” Chief Executive Officer Yaky Yanay said.

Biologists work in a laboratory at Pluristem Theraputics in Haifa

BGU researchers discover sense of ‘touch’ in blood cells

Lymphocytes found to differentiate healthy cells from sick ones through chemical and mechanical reactions

Ben-Gurion University of the Negev.

USFDA clears Plursitem for expanded access program

Patients suffering from critical limb ischemia can now benefit without being part of clinical trials

A Pluristem scientist at work.